S6 Ep21: Gasparetto Talks Management Strategies for Belantamab Mafodotin–Related Ocular Toxicity in Myeloma
Dec 27, 2021
09:58
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Gasparetto discusses the management of ocular toxicities associated with belantamab mafodotin, the nuances of dose modification, and the potential for retreatment following toxicity resolution.
OncLive® On Air